You are here

Article info

Article menu
XML
Stomach
Original article
Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study

Authors

  1. Correspondence to Toshikazu Ushijima, Division of Epigenomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan; tushijim{at}ncc.go.jp
View Full Text

Citation

Asada K, Nakajima T, Shimazu T, et al
Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study
Gut 2015;64:388-396.

Publication history

  • Received February 21, 2014
  • Revised April 27, 2014
  • Accepted May 8, 2014
  • First published June 2, 2014.
Online issue publication 
February 03, 2015

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/